Interrogating a framework for diabetic retinopathy screening adherence: Qualitative insights from a severely affected and under-adherent population

To validate and expand upon a framework of diabetic retinopathy (DR) screening adherence by examining barriers and facilitators among individuals with severe DR and those under-adherent to screening. From March 2021 to February 2022, we conducted eight remote semi-structured interviews with adults with diabetes across two participant populations: (1) participants with severe DR who had undergone procedures (n = 4) and (2) participants under-adherent to screening, defined as no eye exam in >1 year (n = 4). We recruited participants from the Yale Eye Center and community referrals. During the interviews, we collected demographic data and presented participants with a DR screening adherence framework previously developed by our group. We transcribed all interviews and conducted analyses using a hybrid deductive-inductive analytic approach informed by grounded theory techniques to identify recurring themes. Themes across both participant populations aligned with the existing framework, including vision status, emotional context, competing concerns, resource availability, cues to action, knowledge-creating experiences, and in-clinic experiences. The patient-doctor relationship emerged as a sub-theme of in-clinic experiences, highlighting the role of trust and communication in supporting sustained eye care engagement. At the individual level, participants with stable vision often perceived no need for screening. At the institutional and structural level, participants identified lack of insurance and transportation as significant barriers. These findings support the robustness of the DR screening adherence framework across varying levels of disease severity and engagement. Interventions that improve patient education, address structural barriers, and strengthen patient-doctor relationships may enhance screening adherence among populations at high risk for vision loss.

Authors

Institutions

Publication Details

Journal
PLOS Global Public Health
Published
2026-04-02
DOI
https://doi.org/10.1371/journal.pgph.0006230
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interrogating a framework for diabetic retinopathy screening adherence: Qualitative insights from a severely affected and under-adherent population

Elizabeth Fairless, Joana E. Andoh, Kristen Nwanyanwu, Althea Norcott et al.
PLOS Global Public Health
Retinal Diseases and Treatments
article

Interrogating a framework for diabetic retinopathy screening adherence: Qualitative insights from a severely affected and under-adherent population

Elizabeth Fairless, Joana E. Andoh, Kristen Nwanyanwu, Althea Norcott, June Weiss, Julia Fu
article en

Abstract

To validate and expand upon a framework of diabetic retinopathy (DR) screening adherence by examining barriers and facilitators among individuals with severe DR and those under-adherent to screening. From March 2021 to February 2022, we conducted eight remote semi-structured interviews with adults with diabetes across two participant populations: (1) participants with severe DR who had undergone procedures (n = 4) and (2) participants under-adherent to screening, defined as no eye exam in >1 year (n = 4). We recruited participants from the Yale Eye Center and community referrals. During the interviews, we collected demographic data and presented participants with a DR screening adherence framework previously developed by our group. We transcribed all interviews and conducted analyses using a hybrid deductive-inductive analytic approach informed by grounded theory techniques to identify recurring themes. Themes across both participant populations aligned with the existing framework, including vision status, emotional context, competing concerns, resource availability, cues to action, knowledge-creating experiences, and in-clinic experiences. The patient-doctor relationship emerged as a sub-theme of in-clinic experiences, highlighting the role of trust and communication in supporting sustained eye care engagement. At the individual level, participants with stable vision often perceived no need for screening. At the institutional and structural level, participants identified lack of insurance and transportation as significant barriers. These findings support the robustness of the DR screening adherence framework across varying levels of disease severity and engagement. Interventions that improve patient education, address structural barriers, and strengthen patient-doctor relationships may enhance screening adherence among populations at high risk for vision loss.

PLOS Global Public HealthVol. 6(4)
Johns Hopkins University (US), University of Utah (US), Johns Hopkins Medicine (US), Yale University (US), Melinta Therapeutics (United States) (US), Johns Hopkins Hospital (US)
Research to Prevent Blindness, Yale University, National Eye Institute
Openalex Percentile: Top 23%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.